FWCM
PFE icon

Ferguson Wellman Capital Management’s Pfizer PFE Stock Holding History

Ferguson Wellman Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$766K Buy
31,793
+435
+1% +$11.4K 0.01% 258
2026
Q1 		$881K Sell
31,358
-3,466
-10% -$92.3K 0.01% 229
2025
Q4 		$867K Buy
34,824
+218
+0.6% +$5.5K 0.01% 194
2025
Q3 		$882K Sell
34,606
-4,913
-12% -$121K 0.01% 196
2025
Q2 		$958K Sell
39,519
-965
-2% -$22.5K 0.02% 184
2025
Q1 		$1.03M Sell
40,484
-10,782
-21% -$282K 0.02% 183
2024
Q4 		$1.36M Sell
51,266
-7,292
-12% -$198K 0.03% 164
2024
Q3 		$1.69M Sell
58,558
-804
-1% -$23.5K 0.03% 149
2024
Q2 		$1.66M Sell
59,362
-19,430
-25% -$535K 0.03% 141
2024
Q1 		$2.19M Sell
78,792
-8,079
-9% -$224K 0.04% 133
2023
Q4 		$2.5M Sell
86,871
-526,881
-86% -$15.9M 0.06% 127
2023
Q3 		$20.4M Sell
613,752
-26,439
-4% -$935K 0.5% 58
2023
Q2 		$23.5M Sell
640,191
-29,323
-4% -$1.14M 0.55% 54
2023
Q1 		$27.3M Sell
669,514
-713,989
-52% -$30.8M 0.69% 45
2022
Q4 		$70.9M Buy
1,383,503
+719,540
+108% +$34.5M 1.85% 13
2022
Q3 		$29.1M Buy
663,963
+12,129
+2% +$589K 1.14% 29
2022
Q2 		$34.2M Sell
651,834
-285,248
-30% -$14.5M 1.27% 21
2022
Q1 		$48.5M Sell
937,082
-16,169
-2% -$839K 1.53% 14
2021
Q4 		$56.3M Buy
953,251
+47,761
+5% +$2.37M 1.64% 12
2021
Q3 		$38.9M Buy
905,490
+393,460
+77% +$17.4M 1.26% 22
2021
Q2 		$20.1M Buy
512,030
+402,692
+368% +$15.7M 0.65% 53
2021
Q1 		$3.96M Sell
109,338
-15,149
-12% -$538K 0.14% 99
2020
Q4 		$4.58M Sell
124,487
-10,820
-8% -$397K 0.11% 136
2020
Q3 		$4.71M Sell
135,307
-1,913
-1% -$67.1K 0.13% 126
2020
Q2 		$4.26M Sell
137,220
-1,619
-1% -$55K 0.13% 124
2020
Q1 		$4.3M Sell
138,839
-5,985
-4% -$204K 0.16% 116
2019
Q4 		$5.38M Sell
144,824
-409
-0.3% -$14.6K 0.16% 120
2019
Q3 		$4.95M Buy
145,233
+21,559
+17% +$784K 0.16% 114
2019
Q2 		$5.08M Sell
123,674
-154,225
-55% -$6.12M 0.17% 110
2019
Q1 		$11.2M Buy
277,899
+1,611
+0.6% +$64.5K 0.38% 75
2018
Q4 		$11.4M Sell
276,288
-4,520
-2% -$188K 0.44% 63
2018
Q3 		$11.7M Buy
280,808
+170
+0.1% +$6.54K 0.39% 73
2018
Q2 		$9.66M Buy
280,638
+5,197
+2% +$178K 0.34% 86
2018
Q1 		$9.28M Buy
275,441
+7,166
+3% +$246K 0.33% 92
2017
Q4 		$9.22M Buy
268,275
+1,561
+0.6% +$53.2K 0.32% 90
2017
Q3 		$9.03M Buy
266,714
+121,839
+84% +$3.92M 0.33% 89
2017
Q2 		$4.62M Sell
144,875
-5,023
-3% -$158K 0.17% 120
2017
Q1 		$4.87M Sell
149,898
-3,977
-3% -$125K 0.19% 121
2016
Q4 		$4.74M Buy
153,875
+11,253
+8% +$344K 0.19% 117
2016
Q3 		$4.58M Sell
142,622
-7,258
-5% -$243K 0.2% 112
2016
Q2 		$5.01M Sell
149,880
-8,364
-5% -$267K 0.21% 111
2016
Q1 		$4.45M Sell
158,244
-24,415
-13% -$697K 0.19% 118
2015
Q4 		$5.59M Sell
182,659
-276,067
-60% -$8.68M 0.23% 111
2015
Q3 		$13.7M Buy
458,726
+7,329
+2% +$235K 0.61% 54
2015
Q2 		$14.4M Sell
451,397
-7,623
-2% -$248K 0.59% 58
2015
Q1 		$15.2M Sell
459,020
-6,524
-1% -$207K 0.62% 55
2014
Q4 		$13.8M Sell
465,544
-13,951
-3% -$400K 0.55% 61
2014
Q3 		$13.5M Sell
479,495
-934,745
-66% -$26.2M 0.57% 61
2014
Q2 		$39.8M Buy
1,414,240
+227,325
+19% +$6.48M 1.68% 9
2014
Q1 		$36.2M Buy
1,186,915
+371,918
+46% +$11.1M 1.61% 13
2013
Q4 		$23.7M Buy
814,997
+655,900
+412% +$19.1M 1.07% 31
2013
Q3 		$4.34M Sell
159,097
-4,176
-3% -$114K 0.22% 111
2013
Q2 		$4.34M Buy
+163,273
New +$4.51M 0.33% 65

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Ferguson Wellman Capital Management's PFE Position: Q2 2026 in Review

Ferguson Wellman Capital Management increased its Pfizer (PFE) stake by 1.4% in Q2 2026, buying an estimated $11.4K and bringing the position to 31,793 shares worth $766K. The position accounts for 0.01% of the portfolio, ranked #258.

Ferguson Wellman Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $70.9M in Q4 2022. 990 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ferguson Wellman Capital Management held 31,793 shares of Pfizer worth $766K as of Q2 2026.
  • Ferguson Wellman Capital Management bought 435 Pfizer shares in Q2 2026, an estimated $11.4K.
  • Pfizer made up 0.01% of Ferguson Wellman Capital Management's portfolio in Q2 2026, its #258 holding.
  • Ferguson Wellman Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Ferguson Wellman Capital Management's Pfizer position peaked at $70.9M in Q4 2022.
  • 990 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ferguson Wellman Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.